Curocell (XKRX:372320) Cash Flow for Lease Financing : ₩ Mil (TTM As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Curocell Cash Flow for Lease Financing?

Curocell's Cash Flow for Lease Financing for the six months ended in Jun. 2023 was ₩-308.94 Mil. Curocell does not have enough years/quarters to calculate the Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2023.

Compared with last quarter (₩-194.66 Mil in Dec. 2022 ), Curocell's Cash Flow for Lease Financing remained the same in Jun. 2023 (₩-308.94 Mil).

Curocell Cash Flow for Lease Financing Historical Data

The historical data trend for Curocell's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Cash Flow for Lease Financing Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Lease Financing

-117.67

-325.55

-358.91

-383.65

-420.09

Curocell Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
Cash Flow for Lease Financing	-188.99	-194.66	-308.94	-111.15

Curocell Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

Curocell Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Curocell's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines